Q32 Bio (QTTB) Shareholder's Equity Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,253.79% |
| Dec 31, 2025 | 640.33% |
| Sep 30, 2025 | -200.84% |
| Jun 30, 2025 | -136.51% |
| Mar 31, 2025 | -108.23% |
| Dec 31, 2024 | 103.10% |
| Sep 30, 2024 | 111.69% |
| Jun 30, 2024 | 123.48% |
| Mar 31, 2024 | 135.54% |
| Dec 31, 2023 | -39.94% |
| Sep 30, 2023 | -174.84% |
| Jun 30, 2023 | -159.40% |
| Mar 31, 2023 | -151.54% |
| Dec 31, 2022 | -177.05% |
| Sep 30, 2022 | 5.28% |
| Jun 30, 2022 | 7.00% |
| Mar 31, 2022 | 32.58% |
| Dec 31, 2021 | -13.44% |
| Sep 30, 2021 | 16.65% |
| Jun 30, 2021 | 15.34% |
| Mar 31, 2021 | -11.35% |
| Dec 31, 2020 | -24.18% |
| Sep 30, 2020 | -33.98% |
| Jun 30, 2020 | -31.62% |
| Mar 31, 2020 | 30.00% |
| Dec 31, 2019 | 31.65% |
| Sep 30, 2019 | 20.37% |
| Jun 30, 2019 | 25.12% |
| Mar 31, 2019 | 454.06% |
| Dec 31, 2018 | 597.68% |